Adawi Kamal — SEC Form 4 filings

SEC reporting owner CIK 1788393. 5 Form 4 filings on record with FilingPulse; latest filed 2026-01-16.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-02-08 to 2026-01-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
EXAGEN INC. (XGN)CFO and Corporate Secretary33 legs · 19,522 sh · $37,5401
FATE THERAPEUTICS INC (FATE)Chief Financial Officer24

Form 4 filings — Adawi Kamal

FiledFormIssuerReported transactionsSource
2026-01-164FATE THERAPEUTICS INC (FATE)Grant/award (A): 25,000 @ $0 · Grant/award (A): 75,000 (derivative) @ $0EDGAR
2025-10-214FATE THERAPEUTICS INC (FATE)Grant/award (A): 75,000 @ $0 · Grant/award (A): 375,000 (derivative) @ $0EDGAR
2024-03-064EXAGEN INC. (XGN)Sale (S): 9,297 @ $1.91 · Sale (S): 3,487 @ $1.91EDGAR
2024-02-224EXAGEN INC. (XGN)Grant/award (A): 75,000 @ $0EDGAR
2024-02-084EXAGEN INC. (XGN)Sale (S): 6,738 @ $1.95EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1788393 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →